Advertisement
Screener

QUIDELORTHO CORP (QDEL) EBITDA

QUIDELORTHO CORP (QDEL) EBITDA

  • 2026-06-28: Basis Reported; EBITDA $94.9M; Operating income (m); Depreciation and amortization (m).
  • 2026-03-29: Basis Reported; EBITDA $81.1M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-28: Basis Reported; EBITDA $46.2M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-28: Basis Reported; EBITDA -$592.7M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2021-01-03 to 2026-06-28
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-28Reported$94.9M(m)(m)(m)15.04%$25.50M*-$110.60M*(m)$48.70M$189.70M$11.70M
2026-03-29Reported$81.1M(m)(m)(m)13.08%$34.00M-$33.00M(m)$44.90M$199.30M$12.30M
2025-12-28Reported$46.2M(m)(m)(m)6.38%(m)(m)(m)(m)(m)(m)
2025-09-28Reported-$592.7M(m)(m)(m)-84.68%$49.20M*-$45.50M*(m)$41.50M$186.90M-$23.90M
2025-06-29Reported-$70.4M(m)(m)(m)-11.47%$37.50M*-$46.80M*(m)$45.70M$178.00M$25.80M
2025-03-30Reported$139.7M(m)(m)(m)20.16%$56.20M$65.60M(m)$53.20M$187.00M$3.90M
2024-12-29Reported$8.9M(m)(m)(m)1.26%(m)(m)(m)(m)(m)(m)
2024-09-29Reported$128.1M(m)(m)(m)17.62%$46.50M*$117.90M*(m)$55.90M$186.40M-$8.90M
2024-06-30Reported-$1.4M(m)(m)(m)-0.22%$35.30M*-$97.90M*(m)$56.30M$188.20M-$15.20M
2024-03-31Reported-$1.64B(m)(m)(m)-231.10%$66.10M-$700.00K(m)$59.20M$204.70M-$92.90M
2023-12-31Reported$155.5M(m)(m)(m)20.94%(m)(m)(m)(m)(m)(m)
2023-10-01Reported$139.4M(m)(m)(m)18.74%$43.40M*$41.50M*(m)$61.50M$194.10M-$2.80M
2023-07-02Reported$87.6M(m)(m)(m)13.17%$51.30M*-$30.60M*(m)$62.40M$179.10M-$11.20M
2023-04-02Reported$213.8M(m)(m)(m)25.27%$66.00M$188.90M(m)$62.30M$202.40M$11.20M
2023-01-01Reported$203.1M(m)(m)(m)23.44%(m)(m)(m)(m)(m)(m)
2022-10-02Reported$161M(m)(m)(m)20.54%$30.50M*-$9.70M*(m)$65.60M$204.20M$12.10M
2022-07-03Reported$127.2M(m)(m)(m)20.74%$26.20M*$224.70M*(m)$34.20M$118.40M$23.60M
2022-04-03Reported$636M(m)(m)(m)63.45%$22.50M$500.90M(m)$26.40M$84.80M$140.70M
2022-01-02Reported$392.1M(m)(m)(m)61.56%(m)(m)(m)(m)(m)(m)
2021-10-03Reported$294.5M(m)(m)(m)57.77%$106.90M*$77.00M*(m)$23.70M$63.00M$65.80M
2021-07-04Reported$35.6M(m)(m)(m)20.16%(m)(m)(m)$22.60M$54.20M$2.60M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-28Reported-$477.2M(m)(m)(m)-17.48%$188.20M$105.20M(m)$186.20M$746.30M$24.10M
2024-12-29Reported-$1.51B(m)(m)(m)-54.17%$195.10M$83.00M(m)$218.70M$766.80M-$79.50M
2023-12-31Reported$596.3M(m)(m)(m)19.89%$209.30M$280.20M(m)$245.00M$763.20M-$19.00M
2023-01-01Reported$1.13B(m)(m)(m)34.52%$140.90M$885.30M(m)$187.90M$621.00M$187.20M
2022-01-02Reported$958.7M(m)(m)(m)56.44%$292.80M$805.90M(m)$95.70M$239.60M$196.10M
2021-01-03Reported$1.11B(m)(m)(m)66.74%$64.90M$629.70M(m)$84.30M$180.70M$230.00M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92